Mesolimbic Dopamine D3 Receptors and Use of Antipsychotics in Patients With Schizophrenia

Abstract

In contrast to the previously detected elevation of D2 and D4 receptor levels in schizophrenia, elevation of D3 receptor levels in limbic striatum and its efferents observed in patients with schizophrenia may be reduced by antipsychotic drugs.